Andere Sprachen NuGen Medical Devices Inc.

Aktien

A3DABK

CA67054F1009

NGMD

Markt geschlossen - Toronto S.E. Andere Börsenplätze 21:59:59 10.05.2024			% 5 Tage	% 1. Jan.
0,1 ^CAD	0,00 %		0,00 %	-16,67 %

30.04.	NuGen Medical Devices Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI
19.01.	NuGen Medical Devices Inc. erhält zwei weitere Aufträge für InsuJet und weitet den Vertrieb auf Argentinien, Chile, Costa Rica und Peru aus	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

NuGen Medical Devices Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	30.04.
NuGen Announces Debt Settlement and Amendments to Care4Pharma Share Purchase Agreement	15.04.
NuGen Announces Completion of Product Training with Sol Millennium as European Markets Expand	30.01.
NuGen Medical Devices Inc. Receives Two Additional Sales Orders for InsuJet and Expands Distribution into Argentina, Chile, Costa Rica and Peru	19.01.
NuGen Receives Two Additional Sales Orders for InsuJet(TM) and Expands Distribution into Argentina, Chile, Costa Rica and Peru	19.01.
NuGen Medical Signs 5-year Distribution Agreement for InsuJet(TM) with Verrue Consulting Group in Belgium	19.12.
NuGen Medical Devices Inc. Signs 5-Year Distribution Agreement for InsuJet with Verrue Consulting Group in Belgium	19.12.
NuGen Medical Signs 5-Year Distribution Agreement for InsuJet(TM) with Advance Medical Life Co.	14.12.
NuGen Medical Signs 5-Year Distribution Agreement for InsuJet with Advance Medical Life	14.12.
NuGen Medical Devices names veteran medical executive Ian Heynen as Chief Executive Officer	11.12.
NuGen Medical Devices Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	29.11.
NuGen Medical Devices Inc. Reports Distribution Agreement with Science-Link Trading SAPI de CV	14.11.
InsuJet(TM) Registered as a Medical Device in Mexico	13.11.
Nugen Medical Devices Inc. Announces the Official Launch on Shopify of Its Diabetic's Lifestyle Subscription Business	07.11.
Diabetic Lifestyle Subscription Business Launched on Shopify as NuGen's B2C Business Vertical	07.11.
MedTech Industry Leader Ian Heynen Commences CEO Role at NuGen	02.11.
NuGen Medical Devices Inc. Announces Chief Executive Officer Changes	12.10.23
NuGen Medical Appoints Industry Leader Ian Heynen as CEO	12.10.23
NuGen Medical Devices Inc. Presents New Data from Preliminary Trial That Semaglutide (Ozempic ) Is Chemically Stable After It Is Administered Through Nugen 's InsuJet Needle-Free Injection Device	10.10.23
Semaglutide - Ozempic(R) is Chemically Stable When Administered Using NuGen's Needle Free InsuJet(TM) Device	10.10.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen NuGen Medical Devices Inc.

Aktien

A3DABK

CA67054F1009

NGMD

Andere Sprachen

Filter